Sangwook Cheon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sangwook Cheon has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Seogsong Jeong
Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea
3 shared publications - Eun Seok Kang
Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea
2 shared publications - Hwamin Lee
Korea University College of Medicine
2 shared publications - Hye Jun Kim
Seoul National University College of Medicine
2 shared publications - Jin-Hyun Park
Department of Biomedical Informatics, Korea University College of Medicine, 161, Jeongneung-ro, Seongbuk-gu, Seoul, 02708, Republic of Korea, 82 2-3407-2099
2 shared publications - Minjeong Kang
Korea University College of Medicine
2 shared publications
Latest Publications
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study
Background: Older adults with metabolic dysfunction–associated steatotic liver disease have elevated cardiovascular disease (CVD) risk, yet conventional models, such as the Framingham Risk Score, rely on linear assumptions and were developed for younger populations. Nonlinear machine learning approaches may improve risk prediction in this high‐risk group. Methods: Using Korean National Health Insurance Service data, this population‐based cohort study followed up 67 575 adults, aged ≥65 years, with metabolic dysfunction–associated steatotic liver disease (assessed 2009–2010) for incident CVD, coronary heart disease, and stroke from 2011 to 2019. Cox proportional hazards (CoxPH) models identified time‐to‐event predictors, whereas an extreme gradient boosting (XGBoost)–based survival model explored nonlinear associations and predicted 9‐year CVD risk. Results: Both CoxPH and XGBoost models outperformed the Framingham Risk Score, with CoxPH showing slightly better discrimination than XGBoost in the validation sets. The 2 models identified broadly similar leading predictors. For coronary heart disease, both identified Charlson comorbidity index, antiplatelet agent use, and serum creatinine among the most important predictors. In the CoxPH model, the Charlson comorbidity index had the highest explained relative risk (0.031), and the XGBoost model also ranked Charlson comorbidity index first by Shapley Additive Explanations value (0.159). For stroke, both models identified age, Charlson comorbidity index, and antiplatelet agent use as the top 3 predictors, with age ranked first (explained relative risk, 0.065; Shapley Additive Explanations, 0.239). Similar findings were observed for total CVD. Conclusions: In older adults with metabolic dysfunction–associated steatotic liver disease, CoxPH and survival XGBoost showed similar predictive performance and identified key predictors not emphasized in traditional models, like the Framingham Risk Score. These findings underscore limitations of applying younger‐population–based tools to older adults with metabolic dysfunction–associated steatotic liver disease and support the development of tailored CVD risk models.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study
Background: Older adults with metabolic dysfunction–associated steatotic liver disease have elevated cardiovascular disease (CVD) risk, yet conventional models, such as the Framingham Risk Score, rely on linear assumptions and were developed for younger populations. Nonlinear machine learning approaches may improve risk prediction in this high‐risk group. Methods: Using Korean National Health Insurance Service data, this population‐based cohort study followed up 67 575 adults, aged ≥65 years, with metabolic dysfunction–associated steatotic liver disease (assessed 2009–2010) for incident CVD, coronary heart disease, and stroke from 2011 to 2019. Cox proportional hazards (CoxPH) models identified time‐to‐event predictors, whereas an extreme gradient boosting (XGBoost)–based survival model explored nonlinear associations and predicted 9‐year CVD risk. Results: Both CoxPH and XGBoost models outperformed the Framingham Risk Score, with CoxPH showing slightly better discrimination than XGBoost in the validation sets. The 2 models identified broadly similar leading predictors. For coronary heart disease, both identified Charlson comorbidity index, antiplatelet agent use, and serum creatinine among the most important predictors. In the CoxPH model, the Charlson comorbidity index had the highest explained relative risk (0.031), and the XGBoost model also ranked Charlson comorbidity index first by Shapley Additive Explanations value (0.159). For stroke, both models identified age, Charlson comorbidity index, and antiplatelet agent use as the top 3 predictors, with age ranked first (explained relative risk, 0.065; Shapley Additive Explanations, 0.239). Similar findings were observed for total CVD. Conclusions: In older adults with metabolic dysfunction–associated steatotic liver disease, CoxPH and survival XGBoost showed similar predictive performance and identified key predictors not emphasized in traditional models, like the Framingham Risk Score. These findings underscore limitations of applying younger‐population–based tools to older adults with metabolic dysfunction–associated steatotic liver disease and support the development of tailored CVD risk models.
- 14 June 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 290, 36-45
Noncombustible Nicotine or Tobacco Product Use After Smoking Cessation and Major Vision-Impairing Diseases: A Nationwide Cohort Study
- 14 June 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 290, 36-45
Noncombustible Nicotine or Tobacco Product Use After Smoking Cessation and Major Vision-Impairing Diseases: A Nationwide Cohort Study
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41
Association Between Estimated Head Non-Lean Mass and the Risk of Major Mental Disorders: Nationwide Cohort Study in Korea
Kim Y, et al. J Korean Med Sci. 2026 Dec;41:e314. https://doi.org/10.3346/jkms.2026.41.e314
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41
Open AccessAssociation Between Estimated Head Non-Lean Mass and the Risk of Major Mental Disorders: Nationwide Cohort Study in Korea
Kim Y, et al. J Korean Med Sci. 2026 Dec;41:e314. https://doi.org/10.3346/jkms.2026.41.e314